Symbiox Investment [SYMBIOX] vs Raymond [RAYMOND] Detailed Stock Comparison
Symbiox Investment
BSE
Loading...
Raymond
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Symbiox Investment wins in 10 metrics, Raymond wins in 9 metrics, with 0 ties. Symbiox Investment appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Symbiox Investment | Raymond | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.63 | 93.84 | Symbiox Investment |
| Price-to-Book Ratio | 0.27 | 1.09 | Symbiox Investment |
| Debt-to-Equity Ratio | 0.00 | 17.81 | Symbiox Investment |
| PEG Ratio | 0.04 | -3.39 | Raymond |
| EV/EBITDA | -15.06 | 25.14 | Symbiox Investment |
| Profit Margin (TTM) | 8.70% | 271.84% | Raymond |
| Operating Margin (TTM) | 19.32% | 3.39% | Symbiox Investment |
| EBITDA Margin (TTM) | 19.32% | 3.39% | Symbiox Investment |
| Return on Equity | 0.60% | 183.56% | Raymond |
| Return on Assets (TTM) | 0.60% | 98.90% | Raymond |
| Free Cash Flow (TTM) | $35.83M | $752.80M | Raymond |
| 1-Year Return | -36.18% | -66.14% | Symbiox Investment |
| Price-to-Sales Ratio (TTM) | 2.98 | 1.97 | Raymond |
| Enterprise Value | $-51.07M | $44.61B | Raymond |
| EV/Revenue Ratio | -1.76 | 2.17 | Symbiox Investment |
| Gross Profit Margin (TTM) | 49.18% | 40.59% | Symbiox Investment |
| Revenue per Share (TTM) | $1 | $309 | Raymond |
| Earnings per Share (Diluted) | $0.08 | $6.47 | Raymond |
| Beta (Stock Volatility) | -1.22 | -0.06 | Symbiox Investment |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Symbiox Investment vs Raymond Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Symbiox Investment | 0.36% | 2.97% | -2.12% | -4.81% | -17.56% | -47.34% |
| Raymond | -5.25% | -2.16% | -1.88% | 1.37% | -57.50% | -64.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Symbiox Investment | -36.18% | -63.70% | 201.09% | -79.88% | -79.88% | -79.88% |
| Raymond | -66.14% | -40.85% | 111.44% | 39.06% | 61.76% | 53.65% |
News Based Sentiment: Symbiox Investment vs Raymond
Symbiox Investment
News based Sentiment: NEUTRAL
The month's events primarily consist of routine corporate governance activities – a board meeting, an AGM announcement, and a regulatory filing. While important for maintaining a healthy company structure, these events don't represent significant shifts in strategy or performance, resulting in a neutral overall sentiment.
Raymond
News based Sentiment: MIXED
September presented a mixed bag for Raymond, with positive developments in real estate expansion and financial performance overshadowed by an Income Tax survey and stock underperformance. The combination of growth initiatives and regulatory concerns creates a complex investment narrative, making this a significant month for the company.
Performance & Financial Health Analysis: Symbiox Investment vs Raymond
| Metric | SYMBIOX | RAYMOND |
|---|---|---|
| Market Information | ||
| Market Cap | ₹86.67M | ₹40.49B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 55,368 | 204,442 |
| 90 Day Avg. Volume | 57,405 | 325,468 |
| Last Close | ₹2.78 | ₹575.25 |
| 52 Week Range | ₹2.33 - ₹6.02 | ₹523.10 - ₹1,908.00 |
| % from 52W High | -53.82% | -69.85% |
| All-Time High | ₹26.20 (Feb 01, 2016) | ₹3,496.00 (Jul 08, 2024) |
| % from All-Time High | -89.39% | -83.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.47% | -0.44% |
| Quarterly Earnings Growth | 10.95% | -0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 2.72% |
| Operating Margin (TTM) | 0.19% | 0.03% |
| Return on Equity (TTM) | 0.01% | 1.84% |
| Debt to Equity (MRQ) | 0.00 | 17.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹10.14 | ₹558.44 |
| Cash per Share (MRQ) | ₹4.40 | ₹114.41 |
| Operating Cash Flow (TTM) | ₹36.19M | ₹69.27B |
| Levered Free Cash Flow (TTM) | ₹1.92M | ₹76.31B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Symbiox Investment vs Raymond
| Metric | SYMBIOX | RAYMOND |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.63 | 93.84 |
| Forward P/E | N/A | 4.68 |
| PEG Ratio | 0.04 | -3.39 |
| Price to Sales (TTM) | 2.98 | 1.97 |
| Price to Book (MRQ) | 0.27 | 1.09 |
| Market Capitalization | ||
| Market Capitalization | ₹86.67M | ₹40.49B |
| Enterprise Value | ₹-51,065,096 | ₹44.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -1.76 | 2.17 |
| Enterprise to EBITDA | -15.06 | 25.14 |
| Risk & Other Metrics | ||
| Beta | -1.22 | -0.06 |
| Book Value per Share (MRQ) | ₹10.14 | ₹558.44 |
Financial Statements Comparison: Symbiox Investment vs Raymond
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SYMBIOX | RAYMOND |
|---|---|---|
| Revenue/Sales | ₹4.58M | ₹5.24B |
| Cost of Goods Sold | ₹2.33M | ₹3.11B |
| Gross Profit | ₹2.25M | ₹2.13B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹885,000 | ₹177.70M |
| EBITDA | ₹911,000 | ₹852.70M |
| Pre-Tax Income | ₹904,000 | ₹282.10M |
| Income Tax | ₹235,000 | ₹75.90M |
| Net Income (Profit) | ₹669,000 | ₹53.28B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SYMBIOX | RAYMOND |
|---|---|---|
| Cash & Equivalents | ₹10.59M | ₹343.70M |
| Total Current Assets | ₹319.51M | ₹52.03B |
| Total Current Liabilities | ₹2.42M | ₹30.16B |
| Long-Term Debt | ₹0 | ₹3.45B |
| Total Shareholders Equity | ₹317.24M | ₹41.58B |
| Retained Earnings | ₹3.93M | ₹18.59B |
| Property, Plant & Equipment | ₹151,563 | ₹8.90B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SYMBIOX | RAYMOND |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SYMBIOX | RAYMOND |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 55,368 | 204,442 |
| Average Daily Volume (90 Day) | 57,405 | 325,468 |
| Shares Outstanding | 31.29M | 66.55M |
| Float Shares | 24.61M | 30.05M |
| % Held by Insiders | 0.18% | 0.52% |
| % Held by Institutions | 0.00% | 0.14% |
Dividend Analysis & Yield Comparison: Symbiox Investment vs Raymond
| Metric | SYMBIOX | RAYMOND |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹5.33 |
| 3-Year Avg Dividend Yield | N/A | 0.31% |
| 3-Year Total Dividends | N/A | ₹16.00 |
| Ex-Dividend Date | N/A | Jun 13, 2024 |